Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
纳武利尤单抗联合伊匹木单抗,加或不加立体定向放射治疗治疗晚期默克尔细胞癌:一项随机、开放标签的 II 期试验
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(22)01659-2
Kim, Sungjune; Wuthrick, Evan; Blakaj, Dukagjin; Eroglu, Zeynep; Verschraegen, Claire; Thapa, Ram; Mills, Matthew; Dibs, Khaled; Liveringhouse, Casey; Russell, Jeffery; Caudell, Jimmy J; Tarhini, Ahmad; Markowitz, Joseph; Kendra, Kari; Wu, Richard; Chen, Dung-Tsa; Berglund, Anders; Michael, Lauren; Aoki, Mia; Wang, Min-Hsuan; Hamaidi, Imene; Cheng, Pingyan; de la Iglesia, Janis; Slebos, Robbert J; Chung, Christine H; Knepper, Todd C; Moran-Segura, Carlos M; Nguyen, Jonathan V; Perez, Bradford A; Rose, Trevor; Harrison, Louis; Messina, Jane L; Sondak, Vernon K; Tsai, Kenneth Y; Khushalani, Nikhil I; Brohl, Andrew S